Stem cell institute, Evotec target amyotrophic lateral sclerosis

09/12/2013 | GenomeWeb Daily News (free registration)

Evotec and the Harvard Stem Cell Institute will collaborate in the discovery of compounds that inhibit the loss of motor neurons, which has been linked to amyotrophic lateral sclerosis. The partners will use tests based on ALS patient-derived induced pluripotent stem cells that were developed by two faculty members of the institute.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA